Clinical Trials Logo

PV Leukocidin clinical trials

View clinical trials related to PV Leukocidin.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT03367624 Recruiting - Influenza Clinical Trials

Epidemiology of Post-influenza Bacterial Pneumonia Due to a Panton-Valentine Leukocidin Positive Staphylococcus Aureus

FLUVALENTINE
Start date: October 1, 2017
Phase: N/A
Study type: Observational

Secondary bacterial influenza pneumonia caused by Panton-Valentine Leukocidin Positive Staphylococcus aureus is a rare complication but with poor prognosis. This pathology seems to affect young patients (20-40 years) without any medical history. Since the influenza pandemic of 2009, this complication is more and more mentioned, sought and diagnosed. However, the literature is poor, consisting of case reports, experimental studies on murine models, and low-power studies. The main objective is to evaluate the mortality in intensive care units of patients post-influenza bacterial pneumonia due to a Panton-Valentine Leukocidin positive Staphylococcus aureus